Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

OPS-2071 shows potent in vitro and in vivo activity against Clostridioides difficile

June 29, 2021

iLeukPulm study of inhaled Leukine for COVID-19 shows improved oxygenation

June 28, 2021

New resveratrol derivatives against H. pylori resistance

June 28, 2021

AstraZeneca initiates phase II/III study of COVID-19 variant vaccine AZD-2816

June 28, 2021

First data presented for diarylquinoline TBAJ-876 as antimycobacterial compound

June 28, 2021

TPR-1 shows antibacterial activity in a panel of F. tularensis strains and a lethal infection model

June 28, 2021

SelectImmune Pharma and Lonza collaborate to develop processes for novel immunotherapy protein NlpD

June 25, 2021

Tiziana prepares for phase II trial of intranasal foralumab in severe COVID-19

June 23, 2021

New generation of antifungal membrane active peptides from combinatorial library screening

June 23, 2021

Augmenta and TFF select first lead monoclonal antibody candidate against COVID-19

June 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...